Journal of Cancer Research and Clinical Practice

Journal of Cancer Research and Clinical Practice (JCRCP) is an International Peer-reviewed Double-Blind Open Access Journal that aims to promote present clinical research on oncology that may play a significant role in the prevention and cure of large families of Cancer and updates recent studies related to the Clinical Practice of Cancer Science Cancer Surgery and Therapy.

Translational Therapeutics

Translational Therapeutics is dedicated to scientific work that has possible direct applicability in clinical uses or opens new avenues for treatments. The type of manuscript ranges from basic research to early informative clinical trials with extensive concomitant biomaterial analyses. Translational concepts include new computational or wet lab Technologies as well.

Molecular Diagnostics

The Molecular Diagnostic subject category considers studies that examine genomic, transcriptomic, epigenomic, and proteomic biomarkers in the context of cancer diagnosis, staging, prognosis, therapeutic prediction, and radiographic and pathologic characteristics. We are particularly interested in papers that explore novel or evolving biomarkers with direct clinical applicability in cancer care.

Genetics and Genomics

This subject category covers the use of genetic epidemiology and bioinformatics, together with molecular and cell biology, to identify and characterize the genetic and epigenetic factors underlying tumor development and progression. We are interested in papers that focus on the mechanistic consequences of genetic variance, and adequately powered studies of how genetic and epigenetic variation impacts patient risk and outcome phenotypes, in particular where these point to new clinical approaches. Wherever possible, bioinformatics analyses should be supported by experimental results.

Cellular and Molecular Biology

The Cellular and Molecular Biology subject category considers studies that provide novel insight into basic cellular and molecular mechanisms of cancer, but are not biomarker, methodology, or pathology focused. Studies considered for this category will generally go beyond in vitro and/or in silico evaluation of basic cellular and molecular mechanisms of cancer, and usually include the use of appropriate in vivo model systems. Findings of studies considered for this category should be clinically and/or therapeutically applicable.

Epidemiology

The Epidemiology subject category focuses on prevention, early detection, and factors that influence the risk and prognosis of cancer.